| Literature DB >> 35836926 |
Xiangwen Wang1, Dan Mu1, Anyang Geng1, Anqi Zhao1, Yiyuan Song2.
Abstract
Background: Overweight and obesity have been reported in specific patients and disease survivors compared to other types of childhood cancer. This study is aimed at determining the effect of children's obesity on the mortality of acute lymphoblastic leukemia. Method: Children admitted to Inner Mongolia International Mongolian Hospital from 1 January 2017 to 31 December 2020 participated in this study. 1070 children were analyzed. A multi-middle-class poll was conducted. All children under the age of 15 were followed up within 24 months of diagnosis. Overweight and obesity are identified according to the World Health Organization and the Centers for Disease Control and Prevention. Premature death and reoccurrence of emergencies are the main consequences.Entities:
Mesh:
Year: 2022 PMID: 35836926 PMCID: PMC9276514 DOI: 10.1155/2022/4880151
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.809
Two factors that first relapse and die early in the first 24 months of diagnosis.
| Transition | Quick fall | Untimely death | ||||
|---|---|---|---|---|---|---|
| Activity | Moratorium | Increase muscle by 95% | Activity | Moratorium | Increase muscle by 95% | |
| Male and female body movements | ||||||
| Female (code) | 54 | 1 | — | 103 | 1 | — |
| Man | 106 | 1.7 | 1.2-2.4 | 110 | 0.8 | 0.6-1.1 |
| Age | ||||||
| 1-9.9 years (contact) | 92 | 1 | — | 111 | 1 | — |
| <1 year | 8 | 2.7 | 1.2-6.4 | 15 | 6.4 | 2.9-13.8 |
| >10 years | 60 | 1.6 | 1.1-2.3 | 87 | 2.1 | 1.5-2.9 |
| NCI risk level | ||||||
| Standard (contact information) | 66 | 1 | — | 81 | 1 | — |
| Quttiktuq | 94 | 1.9 | 1.4-2.8 | 132 | 2.5 | 1.8-3.3 |
| Immune system | ||||||
| Employment front (contact information) | 138 | 1 | — | 173 | 1 | — |
| Aging | 4 | 1.8 | 0.6-5.9 | 3 | 0.9 | 0.3-3.5 |
| Dual phenoform | 5 | 0.8 | 0.3-2.3 | 7 | 1.0 | 0.4-2.3 |
| T cells | 13 | 0.8 | 0.4-1.5 | 30 | 1.8 | 1.1-2.8 |
| Socioeconomic status | ||||||
| High (contact information) | 32 | 1 | — | 32 | 1 | — |
| Mild nutritional status | 127 | 0.6 | 0.4-0.9 | 173 | 0.9 | 0.6-1.3 |
| Centralized health and intervention programs (%) | ||||||
| General (p5-84.9) (contact information) | 79 | 1 | — | 95 | 1 | — |
| Weight (p85-94.9) | 19 | 1.1 | 0.6-1.9 | 29 | 1.5 | 0.9-2.4 |
| Obesity (>p95) | 25 | 1.4 | 0.8-2.2 | 39 | 1.9 | 1.3-3.0 |
| World Health Organization (Z-class) | ||||||
| General (-1.9-0.9) (contact information) | 96 | 1 | — | 118 | 1 | — |
| Overweight (1-1.9) | 28 | 0.9 | 0.6-1.5 | 45 | 1.4 | 0.9-2.0 |
| Weight (2-2.9) | 18 | 1.4 | 0.8-2.4 | 25 | 1.6 | 1.0-2.7 |
| Obesity (>3) | 8 | 1.3 | 0.6-2.8 | 12 | 1.7 | 0.8-3.3 |
Figure 1Disease-free survival (early relapses) according to CDC 2000 nutritional classification (three categories).
Figure 2Disease-free survival (early relapses) according to CDC 2000 (two categories).
Figure 3Overall survival up to 24 months according to CDC nutritional status.
Figure 4Disease-free survival (early relapses) according to WHO nutritional classification.
Figure 5Overall survival up to 24 months after diagnosis according to WHO nutritional classification.
Clinical status of patients diagnosed in health centers between 2017 and 2020.
| Transition | Predator | Examine | Handkerchief | |
|---|---|---|---|---|
| He is right | No, sir | |||
| Male-female body movements | ||||
| 684 (54.5) | 595 (55.6) | 89 (48.4) | 0.07 | |
| Female | 570 (45.5) | 475 (44.4) | 95 (51.6) | |
| Fiscal year (year) | ||||
| <1 | 34 (2.7) | 28 (2.6) | 6 (3.3) | 0.29 |
| 1-9.9 | 840 (67.0) | 726 (67.9) | 114 (62.0) | |
| >10 | 380 (30.3) | 316 (29.5) | 64 (38.8) | |
| Socioeconomic status | ||||
| Medium to low | 1043 (85.2) | 902 (85.7) | 141 (82.0) | 0.20 |
| Quttiktuq | 181 (14.8) | 150 (14.3) | 31 (18.0) | |
| Introduction of the white blood cell count (×109/L) | ||||
| <10 | 605 (48.2) | 526 (49.2) | 79 (42.9) | 0.18 |
| 10-49.99 | 373 (29.7) | 306 (28.6) | 67 (36.4) | |
| 50~99.99 | 107 (8.5) | 91 (8.5) | 16 (8.7) | |
| >100 | 169 (13.5) | 147 (13.7) | 22 (12.0) | |
| NCI risk level | ||||
| Standard 2 | 691 (55.1) | 597 (55.8) | 94 (51.1) | 0.24 |
| Quttiktuq | 563 (44.9) | 473 (44.2) | 90 (48.9) | |
| Immune system | ||||
| Introduction to the B-level course | 1077 (85.9) | 915 (85.5) | 162 (88.0) | 0.60 |
| Aging | 20 (1.6) | 16 (1.5) | 4 (2.2) | |
| Dual phenoform | 42 (3.3) | 37 (3.5) | 5 (2.7) | |
| T cells | 115 (9.2) | 102 (9.5) | 13 (7.1) | |
Captain Pearson.